Comparison of 21-Plex PCR and API 20C AUX, MALDI-TOF MS, and rDNA sequencing for a wide range of clinically isolated yeast species: Improved identification by combining 21-Plex PCR and API 20C AUX as an alternative strategy for developing countries by Aarstehfar, A. et al.
ORIGINAL RESEARCH
published: 15 February 2019
doi: 10.3389/fcimb.2019.00021
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 1 February 2019 | Volume 9 | Article 21
Edited by:
Rong Fang,
The University of Texas Medical
Branch at Galveston, United States
Reviewed by:
Maurizio Sanguinetti,









†These authors have contributed
equally to this work
Specialty section:
This article was submitted to
Clinical Microbiology,
a section of the journal
Frontiers in Cellular and Infection
Microbiology
Received: 23 October 2018
Accepted: 22 January 2019
Published: 15 February 2019
Citation:
Arastehfar A, Daneshnia F, Kord M,
Roudbary M, Zarrinfar H, Fang W,
Hashemi SJ, Najafzadeh MJ,
Khodavaisy S, Pan W, Liao W,
Badali H, Rezaie S, Zomorodian K,
Hagen F and Boekhout T (2019)
Comparison of 21-Plex PCR and API
20C AUX, MALDI-TOF MS, and rDNA
Sequencing for a Wide Range of
Clinically Isolated Yeast Species:
Improved Identification by Combining
21-Plex PCR and API 20C AUX as an
Alternative Strategy for Developing
Countries.
Front. Cell. Infect. Microbiol. 9:21.
doi: 10.3389/fcimb.2019.00021
Comparison of 21-Plex PCR and API
20C AUX, MALDI-TOF MS, and rDNA
Sequencing for a Wide Range of
Clinically Isolated Yeast Species:
Improved Identification by
Combining 21-Plex PCR and API 20C
AUX as an Alternative Strategy for
Developing Countries
Amir Arastehfar 1†, Farnaz Daneshnia 1†, Mohammad Kord 2, Maryam Roudbary 3,
Hossein Zarrinfar 4, Wenjie Fang 5, Sayed Jamal Hashemi 2,6,
Mohammad Javad Najafzadeh 7, Sadegh Khodavaisy 2,8*, Weihua Pan 5*, Wanqing Liao 5,
Hamid Badali 9, Sassan Rezaie 2, Kamiar Zomorodian 10, Ferry Hagen 1 and
Teun Boekhout 1,5,11
1 Yeast Biodiversity Department, Westerdijk Fungal Biodiversity Institute, Utrecht, Netherlands, 2Department of Medical
Parasitology and Mycology, Tehran University of Medical Sciences, Tehran, Iran, 3Department of Medical Mycology and
Parasitology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran, 4 Allergy Research Center, Mashhad
University of Medical Sciences, Mashhad, Iran, 5 Shanghai Key Laboratory of Molecular Medical Mycology, Department of
Dermatology, Shanghai Institute of Medical Mycology, Shanghai Changzheng Hospital, Second Military Medical University,
Shanghai, China, 6 Food Microbiology Research Center, Tehran University of Medical Sciences, Tehran, Iran, 7Department of
Parasitology and Mycology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran, 8 Zoonoses
Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran, 9Department of Medical Mycology, Invasive
Fungi Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran, 10Department of Medical
Mycology and Parasitology, Basic Sciences in Infectious Diseases Research Center, School of Medicine, Shiraz University of
Medical Sciences, Shiraz, Iran, 11 Yeast Biodiversity Department, Institute of Biodiversity and Ecosystem Dynamics, University
of Amsterdam, Amsterdam, Netherlands
Occurrence of non-Candida albicans Candida (NCAC) species that are associated with
elevated MIC values and therapeutic failures are increasing. As a result, timely and
accurate means of identification to the species level is becoming an essential part of
diagnostic practices in clinical settings. In this study, 301 clinically isolated yeast strains
recovered from various anatomical sites [Blood (n= 145), other sites (n= 156)] were used
to assess the accuracy and practicality of API 20C AUX and 21-plex PCR compared to
MALDI-TOF MS and large subunit rDNA (LSU rDNA). MALDI-TOF MS correctly identified
98.33% of yeast isolates, 100% of top fiveCandida species, 95.7% of rare yeast species,
while 1.3% of isolates were misidentified. API 20C AUX correctly identified 83.7% of yeast
isolates, 97.2% of top five Candida species, 61.8% of rare yeast species, while 16.2% of
yeast isolates were misidentified. The 21-plex PCR, accurately identified 87.3% of yeast
isolates, 100% of top five Candida species, 72% of rare yeast species, but it misidentified
1.3% of rare yeast species while 9.9% of whole yeast isolates were not identified. The
combination of rapidity of 21-plex PCR and comprehensiveness of API 20C AUX, led
to correct identification of 92% of included yeast isolates. Due to expensiveness of
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MALDI-TOF MS and sequencing, this combination strategy could be the most accurate
and inexpensive alternative identification strategy for developing countries. Moreover, by
the advent and development of cost-effective, reliable, and rapid PCRmachines that cost
130 US dollars, 21-plex could be integrated in routine laboratories of developing and
resource-limited countries to specifically identify 95% causative agents of yeast-related
infections in human. Databases of MALDI-TOF MS, API 20C AUX, and the number of
target species identified by 21-plex require further improvement to keep up with the
diverse spectrum of yeast species.
Keywords: API 20C AUX, 21-plex PCR, MALDI-TOF MS, LSU rDNA sequencing, developing countries
INTRODUCTION
Increasing population of immunocompromised patients and
administration of broad-spectrum antibiotics etc. (Pappas,
2006), led to a higher occurrence of fungal infections in
clinical settings (Yapar, 2014). Among opportunistic yeast
species, Candida albicans is continuously reported to be the
most commonly encountered yeast species (Pappas et al.,
2010). However, applying changes to the clinical practices
and interventions resulted in epidemiological landscape and
emergence of non-Candida albicans Candida (NCAC) species
(Pham et al., 2014). For instance, since the introduction of
echinocandins as a prophylactic antifungal, selective pressure has
aided in emergence of NCAC species that are less susceptible
to this class of antifungals (Pham et al., 2014). Moreover,
more frequent isolation of yeast species exhibited inherent less
susceptibility/acquired resistance to fluconazole and those with
multi-drug resistant traits (MDR) highlight the importance
of correct identification (Pfaller et al., 2008; Bizerra et al.,
2014; Pham et al., 2014; Chowdhary et al., 2016). Due to the
availability of trifle classes of antifungals, monitoring frequency,
and epidemiology of yeast species would become an imperative
practice in clinical routine laboratories.
Traditionally, phenotypic assays such as direct microscopy,
biochemical characterization, and culture are among the most
widely used technique to identify yeast species (Posteraro et al.,
2015). API 20C AUX, Vitek2 YST ID Card, and AuxaColor
are among the most widely exploited biochemical means
of identification (Posteraro et al., 2015; Zhao et al., 2017).
However, these techniques are time-consuming, labor-intensive,
and expensive (Posteraro et al., 2013). Many studies showed that
API kits cannot reliably identify rare yeast species, which are
less susceptible to routinely used antifungals (Castanheira et al.,
2013; Magobo et al., 2014). On the contrary, Sanger sequencing
of common barcoding regions and MALDI-TOF MS proved to
be the most accurate identification tools (Criseo et al., 2015).
Although, these techniques are used in routine laboratories in
developed countries, they are regarded as unaffordable devices
in developed countries (Posteraro et al., 2013; Criseo et al., 2015;
Aslani et al., 2018).
Advances in the machinery of polymerase chain reaction
(PCR) has made this device as an affordable identification tool
for developing and low-resourced countries. Moreover, due to
showing a reasonable reproducibility, WHO recommended PCR
as a reliable identification tool in developing countries (Ragheb
and Jimenez, 2014). Although, commercial PCR machines still
are considered to be expensive (2000–4000 US dollars), it has
been shown that using the most basic off-the-shelf tools, it is
possible to develop reliable, rapid, and cheap (130 US dollars)
PCR machines that without continuous power supply and and
as efficient as commercial PCR machines can amplify PCR
products larger than 1,509 bps (Wong et al., 2015). These kinds
of PCR machines can be easily made and expanded as an in on-
site diagnostic tools in resource-limited countries (Wong et al.,
2015). Unfortunately, there are few PCR-based techniques that
can target a comprehensive list of opportunistic yeast species.
Automated rep-PCR proved to be a reliable, but expensive assay
(Zhao et al., 2017). Recently, Arastehfar et al., have developed
a 21-plex PCR assay that targets the most clinically important
yeast species, which uses the basic chemistry and devices that
are used in routine laboratories (Arastehfar et al., 2018). As
21-plex intended to be used in developing countries, we evaluated
its practicality and accuracy compared to a time-consuming
and widely used biochemical technique in developing countries,
namely API 20C AUX, MALDI-TOF MS, and sequencing of




Due to the diagnostic nature of this study, and the fact that
we did not include any clinical samples (blood, serum, CSF,
urine, etc. . . ) or biopsies derived from patients, we did not have
any consent forms from patients. Isolates investigated in this
study were part of previous studies that had been approved by
the local ethical committees of Mashhad University of Medical
Sciences and Tehran University of Medical Sciences under the
following ethical code numbers IRMUMS fm REC.1397.268, and
IR. TUMS. .SPH.REC.1396.4195. As such, inclusion of clinical
strains in our study did not require institutional ethical approval
according to institutional and national guidelines.
Isolates and Growth Conditions
Two hundred and ninety-eight clinical yeast strains
encompassing a wide range of yeast species that were recovered
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from clinical sources [blood (n = 145), vagina (n = 71), sputum
(n= 35), oral swabs (n= 21), Cerebrospinal fluid (CSF) (n= 8),
urine (n = 7), nail (n = 6), tube aspirate (n = 2), penis (n = 1),
and throat (n = 1)] were retrospectively collected from Iran and
China (Table 1). Due to the importance of Candida auris as an
emerging yeast species, and lack of this species in our clinical
collection, three CBS reference strains were included. These
301 strains were serially numbered from 1 to 301, prepared
as a blinded test set, and three centers were involved for their
identification. In the Netherlands two technicians separately
performed MALDI-TOF MS and API 20C AUX, In China
sequencing of D1/D2 domains of rDNA was carried out, and in
Iran, as an example of a developing country a multiplex PCR
known as 21-plex was utilized. Strains comprised a diverse range
of yeast species, including most and less prevalent Candida
species and basidiomyceteous yeasts, including Trichosporon,
Cryptococcus, and Rhodotorula. Strains were grown on GYPA
and SDA media for 48 h at 25◦C, single colonies were struck
on SDA and GYPA media, incubated another 48 h at 25◦C, and
from those pure cultures identifications were performed.
DNA Extraction
One full loop of pure colonies (with the volume of 10 µl)
was suspended in 100 µl of TaKaRa Lysis buffer (TaKaRa,
Japan), vortexed thoroughly, and incubated at 95◦C for 30. After
15min incubation at 95◦C, lysates were vortexed vigorously and
incubation for another 15min at 95◦C was continued. In the last
step, lysates were vortexed again and centrifuged at 14,000 rpm
for 5min. Two microliters of obtained supernatants were used as
the PCR template.
Sequencing
One technician was responsible for performing sequencing of
D1/D2 domains of rDNA (LSU rDNA), as described previously
(Stielow et al., 2015). Bidirectional chain Terminated Sanger
sequencing using referenced primers were performed. Obtained
sequences were searched in BLAST database (https://blast.ncbi.
nlm.nih.gov) and the identity of each strain was assigned
accordingly. This experiment was carried out in China.
Stepwise 21-Multiplex PCR
Identification of 301 using 21-plex PCR was performed in Iran.
This technique contains three multiplex PCR reactions, with
the first one identifying the most prevalent Candida species
(Table 2), the second one targeting rare Candida species, and the
third multiplex reaction identifying the most clinically important
basidiomyceteous yeast species, i.e., Trichosporon, Cryptococcus,
Geotrichum, and Rhodotorula (Arastehfar et al., 2018). Authors
claimed that except for Candida zeylanoides, the rest of target
species were correctly identified. PCR reaction and program
were used same same as described, previously (Arastehfar et al.,
2018). PCR products were run on 2% agarose gel (voltage of 135,
60min), stained with Gel Red (BioTium Corporation, USA), and
visualized by Gel Doc (Gel Doc XR+, BioRad, California, USA).
This experiment was performed in Iran.
MALDI-TOF MS
Full-extraction method as it was utilized as suggested, previously
(Marklein et al., 2009), and identification was carried out by
using Microflex LT, MALDI-TOF MS device (Bruker Daltonics,
Bremen Germany). Scores lower than 1.7, ≥1.7<2, and above 2
were considered as not reliable identification, identification at the
genus level, and identification at the species level, respectively.
MALDI-TOF MS was performed in Netherlands.
API 20C AUX
API 20C AUX (BioMerieux, France), based on assimilation
of 19 sugars and presence or absence of hyphal/pseudohyphal
formation identifies clinically important yeast species. API
strips were prepared as suggested by the manufacturer and
incubated at 30◦C for 48–72 h. Besides of results obtained from
sugar assimilation profile, the possibility of hyphal/pseudohyphal
formation was investigated as described previously (Keçeli et al.,
2016). As 72 h incubation of API strips improved the accuracy of
results (Willemsen et al., 1997), final sugar assimilation patterns
were read after 72 h incubation at 25◦C. Accurate identification
was based on identity and T indices greater than 90% and
0.75, respectively. For hints lower than those values, the first
proposed identity was assigned as the species name. API 20C
AUX experiments were carried out in the Netherlands.
Statistical Analysis
The strength of agreements between API 20C AUX and
sequencing, 21-plex PCR and sequencing, MALDI-TOF MS
and sequencing was assessed by Kappa coefficient value.
Kappa coefficient value was calculated by SPSS v.23 software
(Chicago, USA).
RESULTS
Comparative Analysis of LSU rDNA
Sequencing and MALDI-TOF MS
Two hundred and ninety-six of isolates (98.33%) were correctly
identified, four isolates (1.3%) misidentified, and only one
isolate was not identified using MALDI-TOF MS (Table 2).
All of those yeast isolates were identified with the score
of over two, indicating reliable identification at the species
level. Surprisingly, two isolates of Meyerozyma guilliermondii
and two isolates of Clavispora lusitaniae were misidentified
as C. dendronema and Wickerhamiela pagnoccae (Table 3),
respectively. Despite of repeated efforts and experiments using
full-extraction method, the same results were obtained. All of
top 5 Candida species [C. albicans, C. glabrata, C. parapsilosis,
C. tropicalis, and Pichia kudriavzevii (Candida krusei)] and
95.7% of rare yeast species were identified, correctly. In total,
MALDI-TOF MS identified 98.33% of yeast isolates. The
Kappa coefficient value for MALDI-TOF MS and sequencing
was 0.991.
Comparative Analysis of LSU rDNA
Sequencing and 21-Plex PCR
Two hundred and sixty-seven isolates (88.7%) were correctly
identified, 4 isolates (1.3%) were misidentified, and 29 isolates
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TABLE 1 | Summary of species utilized in this along with their source of isolation and the country of origin.
Species (number) Source of isolation Country of origin
Candida albicans (n = 59) Blood (n = 52), Vagina (n = 6), Oropharyngeal (n = 1) Iran
Candida glabrata (n=43) Vagina (n = 20), Blood (n = 18), Urine (n = 2), sputum (n = 1), Skin
(n = 1), Penis (n = 1)
Iran
Candida parapsilosis (n = 40) Blood (n = 36), Vagina (n = 3), Nail (n = 1) Iran
Candida tropicalis (n = 14) Blood (n = 13), Nail (n = 1) Iran
Pichia kudriavzevii (Candida krusei) (n = 27) Vagina (n = 20), Blood (n = 5), Throat (n = 1), Urine (n = 1), Iran
Candida dubliniensis (n = 3) Blood (n = 3) Iran
Kluyveromyces marxianus (Candida kefyr) (n = 27) Oropharyngeal (n = 13), Sputum (n = 6), Vagina (n=5), Urine (n = 2),
Blood (n = 1)
Iran
Clavispora lusitaniae (Candida lusitaniae) (n = 21) sputum (n = 7), Oropharyngeal (n = 6), Blood (n = 5), Tracheal Tube
(n = 2), Nail (n = 1),
Iran, China
Meyerozyma guilliermondii (Candida guilliermondii)
(n = 14)
Blood (n = 5), Sputum (n = 5), Nail (n = 1), Oropharyngeal (n = 1),
Urine (n = 1), Vagina (n = 1)
Iran, China
Kodamaea ohmerii (n = 10) Sputum (n = 10) China
Candida metapsilosis (n = 2) Sputum (n = 2) China
Candida orthopsilosis (n = 4) Blood (n = 2), Sputum (n = 1), Nail (n = 1) Iran
Candida bracarensis (n = 1) Sputum (n = 1) China
Cyberlindnera fabianii (Candida fabianii) (n = 5) Vagina (n = 4), Blood (n = 1) Iran
Cyberlindnera jadinii (Candida utilis) (n = 1) Vagina (n = 1) Iran
Candida auris (n = 3) Reference strains (n = 3) Westerdijk Collection (CBS12883,
CBS12884, and CBS12885)
Candida inconspicua (n = 1) Vagina (n = 1) Iran
Pichia cactophila (n = 4) Vagina (n = 4) Iran
Candida vulnera (n = 1) Vagina (n = 1) Iran
Kluyveromyces lactis (n = 1) Vagina (n = 1) Iran
Diutina pararugosa (Candida pararugosa) (n = 1) Vagina (n = 1) Iran
Saccharomyces cerevisiae (n = 1) Nail (n = 1) Iran
Rhodotorula mucilaginosa (n = 2) Vagina (n = 2) Iran, China
Cryptococcus neoformans (n = 6) CSF (n = 5), Blood (n = 1) Iran,
Cryptococcus gattii (n = 3) CSF (n = 3) China
Cryptococcus saitoi (n = 1) Blood (n = 1) Iran
Trichosporon asahii (n = 1) Urine (n = 1) Iran
Trichosporon asteroides (n = 2) Blood (n = 2) Iran, Fang
Trichosporon mucoides (n = 1) Sputum (n = 1) China
Trichosporon faecale (n = 1) Sputum (n = 1) China
Cutaneotrichosporon curvatus (n = 1) Vagina (n = 1) Iran
Total (n = 301)
Except for Candida auris that was ordered from the collection of Westerdijk Institute, the rest of species were collected from patient materials.
(9.96%) were not identified by the 21-plex PCR technique
(Table 2). Both misidentified and none-identified isolates were
rare yeast species (Tables 2, 3), while all of top 5 Candida species
(C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, and P.
kudriavzevii) were identified, correctly. The Kappa coefficient
value for 21-plex PCR and sequencing was 0.943.
Comparative Analysis of LSU rDNA
Sequencing and AP 20C AUX
Two hundred and fifty-one isolates (83.7%) were correctly
identified, 49 (16.2%) isolates were misidentified, and there was
no species without identification using API 20C AUX (Table 2).
The majority of misidentified yeast isolates were among rare
species (n = 45), and only 4 strains of P. kudriavzevii were
among top 5 Candida species (Table 3). API 20C AUX showed
the lowest Kappa Coefficient value (0.918) when compared
to sequencing.
Combined Strategy (API 20C AUX and
21-Plex PCR) for Identification of Yeast
Collection
Although, the 21-plex PCR showed higher accuracy, API
20C AUX more comprehensively identified yeast species. For
instance, species such as Saccharomyces cerevisiae (1/1) and
Kodamaea ohmerii (9/10) were correctly identified by API
20C AUX, while they were not identified by 21-plex PCR. By
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TABLE 2 | Summary of species identification of wide range of clinically obtained yeast species using three approaches, MALDI-TOF MS, 21-plex, API 20C AUX, and their
comparison with large subunit of rDNA domain sequencing.













Candida albicans (n = 59) 59 59 59 – – – – – –
Candida glabrata (n = 42) 43 43 43 – – – – – –
Candida parapsilosis
(n = 40)
40 40 40 – – – – – –
Candida tropicalis (n = 14) 14 14 14 – – – – – –
P. kudriavzevii (n = 27) 27 27 22 – – – – – –
Candida dubliniensis
(n = 3)
3 3 2 – – – – – –
Kluyveromyces marxianus
(n = 27)
27 27 24 – – – – – –
Clavispora lusitaniae
(n = 21)
19 21 17 2 – 4 – – –
Meyerozyma guilliermondii
(n = 14)
12 14 11 2 – 3 – – –
Kodamaea ohmerii
(n = 10)
10 – 9 – – 1 – 10 –
Candida metapsilosis
(n = 2)
2 – – – – 2 – 2 –
Candida orthopsilosis
(n = 4)
4 – – – 4 4 – – –
Candida bracarensis
(n = 1)
1 – – – – 1 – 1 –
Cyberlindnera fabianii
(n = 5)
5 – – – – 5 – 5 –
Cyberlindnera jadinii
(n = 1)
1 – 1 – – – – 1 –
Candida auris (n = 3) 3 3 – – – 3 – – –
Candida inconspicua
(n = 1)
1 – – – – 1 – 1 –
Pichia cactophila (n = 4) 4 – – – – 4 – 4 –
Candida vulnera (n = 1) 1 – – – – 1 – 1 –
Kluyveromyces lactis
(n = 1)
1 – – – – 1 – 1 –
Diutina pararugosa (n = 1) 1 – – – – 1 – 1 –
Saccharomyces
cerevisiae (n = 1)
1 – 1 – – – – 1 –
Rhodotorula mucilaginosa
(n = 2)
2 2 2 – – – – – –
Cryptococcus
neoformans (n = 6)
6 6 6 – – – – – –
Cryptococcus gattii
(n = 3)
3 3 – – – 3 – – –
Cryptococcus saitoi
(n = 1)
1 – – – – 1 – 1 –
Trichosporon asahii (n = 1) 1 1 1 – – – – – –
Trichosporon asteroides
(n = 2)
2 2 – – – 2 – – –
Trichosporon mucoides 1 – – – – 1 – 1 –
Trichosporon faecale 1 1 – – – 1 – – –
Cutaneotrichosporon
curvatus (n = 1)
– 1 – – – 1 1 - –
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TABLE 3 | Misidentified isolates using MALDI-TOF MS, 21-plex, and API 20C AUX compared to LSU rDNA sequencing as the gold standard method.
Species Misidentified as
MALDI-TOF MS 21-plex API 20C AUX
Pichia kudriavzevii (n = 27) – – Candida norvegensis (n = 4), Cryptococcus
humicola (n = 1)
Candida dubliniensis (n = 3) – – Candida albicans (n = 1)
Kluyveromyces marxianus (n = 27) – – Rhodotorula mucilaginosa (n = 2) and Candida
albicans (n = 1)
Clavispora lusitaniae (n = 21) Wickerhamiela pagnoccae (n = 2) – Candida tropicalis(n = 2), Candida parapsilosis
(n = 1) and Candida albicans (n = 1)
Meyerozyma guilliermondii (n = 14) Candida dendronema (n = 2) – Candida lusitaniae (n = 3)
Kodamaea ohmerii (n = 10) – – Candida guilliermondii (n = 1)
Candida metapsilosis (n = 2) – – Candida parapsilosis (n = 2)
Candida orthopsilosis (n = 4) – C. parapsilosis (n = 4) Candida parapsilosis (n = 4)
Candida bracarensis (n = 1) – – Candida glabrata (n = 1)
Cyberlindnera fabianii (n = 5) – – Candida utilis (n = 3), Candida pelliculosa (n = 1),
Candida thermophila (n = 1)
Candida auris (n = 3) – – Rhodtorula glutinis (n = 3)
Candida inconspicua (n = 1) – – Trichosporon asahii (n = 1)
Pichia cactophila (n = 4) – – Candida norvegensis (n = 2), Candida ciferrii
(n = 1), Candida spherica (n = 1)
Candida vulnera (n = 1) – – Kodamaea ohmeri (n = 1)
Kluyveromyces lactis (n = 1) – – Candida kefyr (n = 1)
Candida pararugosa (n = 1) – – Candida rugosa (n = 1)
Cryptococcus gattii (n = 3) – – Cryptococcus neoformans (n = 3)
Cryptococcus saitoi (n = 1) – – Cryptococcus albidus (n = 1)
Trichosporon asteroides (n = 2) – Trichosporon asahii (n = 2) Trichosporon asahii (n = 2)
Trichosporon mucoides (n = 1) – – Trichosporon asahii (n = 1)
Trichosporon faecale (n = 1) – Trichosporon asahii (n = 1) Trichosporon asahii (n = 1)
Cutaneotrichosporon curvatus (n = 1) – Trichosporon asahii (n = 1) Trichosporon asahii (n = 1)
Total number of misidentified isolates n = 4 n = 8 n = 49
integrating the rapidity of PCR and comprehensiveness of API
20C AUX we could correctly identify 92% of yeast isolates
included in our study. As 21-plex PCR represented a fast and
reliable technique for the majority of the more prevalent yeast
species and API 20C AUX requires 48–72 h for identification, we
used 21-plex as the first line and rapid identification tool and in
case of encountering with negative results, API 20C AUX could
be used as the alternative technique.
DISCUSSION
Because the number of yeast species causing infection in
human is increasing, fast, and accurate identification of clinically
obtained isolates is highly important to initiate appropriate
antifungal regimen (Pincus et al., 2007). Sequencing of
commonly used phylogenetic markers, MALDI-TOF MS, PCR-
based techniques, and biochemical and phenotypic assays are
considered as the most popular identification systems. Herein,
we have compared the accuracy of the API 20C AUX and 21-plex
PCR methods in the light of MALDI-TOF MS and sequencing of
D1/D2 domains of rDNA.
In our study, MALDI-TOF MS showed a good accuracy for
identification of a diverse range of opportunistic yeast species
(98.3%). All of five top Candida species (C. albicans, C. glabrata,
C. parapsilosis, C. tropicalis, and P. kudriavzveii) and 95.7% of
rare yeast species were identified successfully (Kappa value of
0.991). Despite the close genetic background of cryptic species
complexes, MALDI-TOF MS identified them to the species level
(note that we did not have C. africana). This is in agreement
with other studies, where cryptic species complexes ofC. albicans,
C. glabrata, and C. parapsilosis were correctly identified (Santos
et al., 2011). Moreover, FDA-approved spectra of wide-spreading
multidrug-resistant yeast species, i.e., Candida auris, has been
added to the clinical database of MALDI-TOF MS, leading to
rapid and reliable identification of this organism (Bao et al.,
2018). Although, cases of misidentification for Cryptococcus and
Trichosporon species had been reported previously (Kolecka
et al., 2013; Sendid et al., 2013; Ling et al., 2014; Zhao et al.,
2017), except for Cutaneotrichosporon curvatus, all of our clinical
isolates of aforementioned species were correctly identified (the
reference spectra of this species is not included in the MALDI-
TOF MS database). Consistent with the other studies and
due to hardship of obtaining proper spectra for Meyerozyma
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guilliermondii (Ling et al., 2014; Zhao et al., 2017), usingMALDI-
TOFMSM. guilliemondii (n= 2/14) andCl. lusitaniae (n= 2/21)
were misidentified in our study. MALDI-TOF MS, despite of
being fast, robust, and providing accurate strain identity is still
considered as an economical burden, especially for developing
countries, not only to purchase the device but also as it requires
trained technicians and periodical maintenances (Posteraro et al.,
2013; Criseo et al., 2015; Aslani et al., 2018). Due to occurrence of
misidentification of some rare yeast species in our study and the
other studies (Sendid et al., 2013; Zhao et al., 2017), improvement
of the MALDI-TOF MS library can enhance the accuracy of
this technique.
Although Vitek 2 YST ID Card reported amongst the
most popular biochemical assays used in routine laboratories
(Posteraro et al., 2015), API 20CAUX showed a higher agreement
with sequencing of ITS and D1/D2 domains of rDNA (Zhao
et al., 2017). As a result, herein API 20C AUX was used as
the representative of biochemical assays. In our study, API 20C
AUX correctly identified 83.7% of all included yeast isolates,
the vast majority (97.26%) of the most prevalent Candida
species (C. albicans, C. glabrata, C. parapsilosis, C. tropicalis,
and P. kudriavzveii) and 61.8% of rare yeast species which
is consistent with previous studies (Keçeli et al., 2016; Zhao
et al., 2017) (Kappa value of 0.918). Despite the fact that, API
20C AUX misidentified the majority (4/5) of Pichia kudriavzevii
strains as Pichia norvegensis, studies have revealed that both
species are inherently resistant to fluconazole and genetically
are close to each other (Sandven et al., 1997; Musso et al.,
2014). Although, identification to the species level is an integral
part of epidemiological studies, grouping of few species with
the same antifungal susceptibility pattern in routine settings
may hasten the timely administration of antifungals and as a
consequence it may contribute to a lower the mortality rate.
For instance, C. albicans, C. parapsilosis, C. tropicalis, and C.
dubliniensis are all susceptible to fluconazole, and hence, using
one probe they were identified as the fluconazole susceptible
group (McMullan et al., 2008). On the other hand, in vitro studies
have shown that C. dubliniensis compared to C. albicans more
rapidly can acquire resistance to antifungals(Moran et al., 1997),
underscoring the importance of specie level identification in such
circumstances.In our study, 66.6% (2/3) of C. dubliniensis strains
were correctly identified, whereas other cryptic complex species
of C. metapsilosis, C. orthospsilosis, and C. bracarensis were all
identified as C. parapsilosis and C. glabrata, which is in agreement
with other reports (Keçeli et al., 2016; Zhao et al., 2017). For other
clinically rare Candida species including M. guilliermondii, Cl.
lusitaniae, and Kl. marxianus we observed few misidentification
cases. All CBS reference strains of C. auris in concordance
with other studies were misidentified as Rhodotorula glutinis
(Magobo et al., 2014). In our setting, application of API 20C
AUX for the most prevalent basidiomyceteous yeasts did not
obtain satisfactory results for Cr. gattii, Trichosporon mucoides,
and T. asteroides as seen with the previous studies (Guo
et al., 2011). Biochemical assays in general and API 20C
AUX in particular, despite of generating satisfactory results
for rare yeast species, are labor-intensive, time-consuming,
and interpretation of sugar assimilation profiles is sometimes
subjective. Moreover, in order to generate accurate identity,
API 20C AUX requires further testing of yeast isolates for
hyphal/pseudohyphal formation (Guo et al., 2011). Numerous
of reports have shown that biochemical assays can lead to
underestimation of some rare yeast species and ignoring them as
etiological agents of infection in human (Kathuria et al., 2015;
Svobodova et al., 2016). As an example, all biochemical assays
provide inaccurate identity for C. auris and it is mistaken for
other yeast species such as C. parapslosis, C. famata, Rhodotorula
glutinis etc (Kordalewska et al., 2017), leading to its persistence
as a colonizer in hospital environment and source of future
outbreaks. Given the rise in occurrence of rare yeast species
that are less susceptible to fluconazole (Miceli et al., 2011),
this could be of a great importance, as in developing countries
due to limited economical support, this drug is administered
as the drug of choice for the first line therapy (Kordalewska
et al., 2018). Consequently, for a species like C. auris that
exhibited resistance to all classes of antifungals, especially more
than 90% resistance to fluconazole (Kathuria et al., 2015),
along with high rate of mortality of 30–60% (Chowdhary
et al., 2017), such misidentifications could be accompanied by
adverse consequences.
Recently, we have developed a multiplex PCR that in a
stepwise manner identifies the majority of yeast species regularly
encountered in clinical settings as the cause of infection in human
(Arastehfar et al., 2018). With the application of 21-plex PCR we
correctly identified 87.3% of all included yeast species, 100% of
most prevalent Candida species and 72% of rare yeast species
(Kappa value of 0.943). As this assay originally was not intended
for identification of other rare yeast species, such as S. cerevisiae,
Cyberlindnera fabianii, Cyberlindnera jadinii, Kodamaea ohmerii,
C. cactophila, C. norvegensis, Kl. lactis, Cryptococcus saitoi,
and T. mucoides, they were not identified, accordingly. This
assay showed a high degree of specificity (98.7%). Although, T.
asteroides (n = 2), T. faecale (n = 1), and Cutaneotrichosporon
curvatus (n = 1) were identified as T. asahii, 21-plex utilizes
one universal primer to identify most clinically important
Trichosporon species in the genus level, and hence, these cases
were not considered as misidentification. Although, a slight
difference in susceptibility pattern of triazoles (ravuconazole,
itraconazole, and voriconazole) and AMB between T.asahii and
non-T. asahii strains have been observed (Paphitou et al., 2002),
MIC values are not always correlated with clinical outcomes
(Paphitou et al., 2002). Accordingly, in order to prove the
difference in clinical outcomes, in vivo testing with neutropenic
and immunocompromised mice is still required. As a result,
identification of species of non-T. asahii and T. asahii to the
genus level (only as Trichosporon) will be clinically relevant,
unless otherwise is proved. In concordance with sequencing of
D1/D2 domains of rDNA and MALDI-TOF MS, all included
strains of C. auris were correctly identified. Other PCR-based
techniques such Rep-PCR shown to be a robust technique to
identify a wide range of yeast species (Pincus et al., 2007;
Zhao et al., 2017), but it requires tedious DNA extraction
methods, capillary electrophoresis for separation of amplified
PCR product, and highly trained personnel (Pincus et al.,
2007; Zhao et al., 2017). Moreover, using rep-PCR technique,
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identification of a single isolate requires 90 USD, while in
our setting using 21-plex costs 0.75–1 euros. Although 21-plex
PCR exhibited a high degree of sensitivity (98.7%), there were
some species (K. ohmerii, C. metapsilosis, and C. bracarensis,
Cy. fabianii and Cr. satoi) that were not identified. As a
result, including more multiplex PCR assays to identify other
clinically important yeast species, can improve the sensitivity
of 21-plex PCR.
Sole dependence on phenotypic assays could result in
misidentification and subsequently oblivion of emerging
and important yeast species, while combination of
comprehensiveness of biochemical and phenotypic assays
with the rapidity of PCR-based techniques (21-plex PCR) could
increase the accuracy of identification, reduces required time and
expenses, and circumvent the imperfection of either assays. For
instance, despite of obtaining negative results using the 21-plex
PCR for strains of K. ohmerii, Cy. jadinii, S. cerevisiae, they were
correctly identified by API 20C AUX. Moreover, 21-plex PCR
due to its rapidity and possessing high specificity and sensitivity,
if accompanied by inexpensive and reliable PCR devices, it could
be used as a reliable means of identification in developing and
resource-limited countries. This could be relevant for routine
laboratories, especially in developing countries, where robust
and accurate means of identification such as MALDI-TOF
MS and Sanger sequencing are lacking. In terms of required
expenses, MALDI-TOF MS was the least expensive (less than
0.3 Euros), followed by 21-plex PCR (0.75–1 Euros/reaction),
sequencing (3 Euros) and API 20C AUX (5.9 Euros/reaction). As
a result, API 20C AUX was the most expensive and least accurate
identification tool.
Despite the fact that we included various rare Candida and
yeast species obtained from multiple healthcare facilities in Iran
and China, our study still could benefit from addition of other
rare yeast species, such Debaromyces hansinii, Diutina rugose,
Yarrowia lipolytica, and the like. Moreover, we did not obtain
clinical isolates of cryptic species complexes of C. nivariensis
and C. africana and hence we could not observe how well they
could be differentiated from C. glabrata and C. albicans using
applied techniques.
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